We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

99 hedge funds and large institutions have $560M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $436M → $560M (+$124M)

9% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 33

4% less funds holding

Funds holding: 103 → 99 (-4)

15% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 26

Holders
99
Holders Change
-4
Holders Change %
-3.88%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
22
Increased
36
Reduced
33
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NIMC
NWQ Investment Management Company
California
+$15.3M
2
Franklin Resources
Franklin Resources
California
+$12.9M
3
PCM
Penn Capital Management
Pennsylvania
+$11.5M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.5M
5
BFA
BlackRock Fund Advisors
California
+$7.79M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$20.7M
2
CS
Credit Suisse
Switzerland
-$13.8M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.55M
4
JP Morgan Chase
JP Morgan Chase
New York
-$7.2M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$3.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$3.77M -$1.33M -58,818 -28%
TCM
27
Timpani Capital Management
Wisconsin
$3.68M +$783K +34,678 +31%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$3.63M +$550K +24,372 +21%
BRWA
29
B. Riley Wealth Advisors
Florida
$3.58M +$3.18M +140,891 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.49M +$788K +34,889 +34%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$3.45M +$3.07M +135,820 New
OAM
32
Oxford Asset Management
United Kingdom
$3.15M -$3.12M -138,343 -53%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$2.85M +$1.06M +47,071 +72%
PCP
34
Perimeter Capital Partners
Georgia
$2.85M -$3.09M -136,804 -55%
WSA
35
Wall Street Associates
California
$2.69M +$2.39M +105,998 New
CCMH
36
Cornerstone Capital Management Holdings
New York
$2.64M +$666K +29,500 +40%
GTC
37
Ghost Tree Capital
New York
$2.54M +$2.26M +100,000 New
Renaissance Technologies
38
Renaissance Technologies
New York
$2.5M +$946K +41,900 +74%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$2.41M +$494K +21,883 +30%
TCIM
40
TIAA CREF Investment Management
New York
$1.98M +$263K +11,638 +18%
DCM
41
Dupont Capital Management
Delaware
$1.98M -$272K -12,054 -13%
Canada Life
42
Canada Life
Manitoba, Canada
$1.96M +$1.74M +76,900 New
Ohio Public Employees Retirement System (OPERS)
43
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.93M +$1.71M +75,945 New
WMSA
44
Weiss Multi-Strategy Advisers
New York
$1.78M -$700K -31,000 -31%
HVC
45
Healthcare Value Capital
New Jersey
$1.49M -$341K -15,100 -20%
Arrowstreet Capital
46
Arrowstreet Capital
Massachusetts
$1.48M +$92.9K +4,113 +8%
FLAM
47
First Light Asset Management
Minnesota
$1.41M +$1.26M +55,619 New
QBFM
48
QS Batterymarch Financial Management
New York
$1.34M -$9.03K -400 -0.8%
BIM
49
BlackRock Investment Management
Delaware
$1.3M +$11.3K +502 +1%
MAA
50
Managed Account Advisors
New Jersey
$1.22M +$1.08M +48,045 New
1
2
3 4 5

SGNT Hedge Fund Activity: Q4 2013 in Review

99 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2013, worth a combined $560M — up 28% from $436M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of SGNT and 22 opened new positions — a net loss of 4 holders — while 33 trimmed existing stakes and 36 added.

The largest buyer was NWQ Investment Management Company, opening a new position worth an estimated $15.3M. The largest seller was Deerfield Management, exiting entirely with an estimated $20.7M sold.

  • 99 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2013, down from 103 in Q3 2013.
  • Funds reported $560M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2013, up 28% quarter-over-quarter.
  • 22 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2013 and 26 closed out, a net change of -4 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2013 was NWQ Investment Management Company, an estimated $15.3M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2013 was Deerfield Management, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2013.